Back

Obese cardiomyopathy and the role of GLP-1

13 May 2024 (08:42 - 08:54)
Organised by: Logo
Congress Presentation Part of: Heart failure management in the cardiometabolic era Comorbidities HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Professor Javed Butler

Baylor Scott & White Health, Dallas (United States of America)

3 More presentations in this session

Presentation thumbnail
Is SiGLT2i the treatment for diabetic cardiomyopathy?
Doctor J. Ferreira (Porto, PT)
Slides Video
Presentation thumbnail
How to manage heart failure in uremic cardiomyopathy
Doctor I. Beldhuis (Groningen, NL)
Slides Video
Presentation thumbnail
Heart failure management in the cardiometabolic era - discussion
Video

Access the full session

Session thumbnail
Heart failure management in the cardiometabolic era
Video

The Event

Event poster

Heart Failure 2024

13 May 2024 08:42 CET
You may be interested in
thumbnail
Congress Presentation
Novel medical approach to treating obesity
18 May 2025
thumbnail
Congress Session
From obesity to heart failure with preserved ejection fraction
10 May 2026
thumbnail
Congress Presentation
Medical treatment of obesity in heart failure
19 May 2025
thumbnail
Congress Presentation
Optimal anti-diabetic medications in patients with heart failure
19 May 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources